DE60035316T2 - Vorrichtung und verfahren zur detektion von analyten in flüssigkeiten - Google Patents
Vorrichtung und verfahren zur detektion von analyten in flüssigkeiten Download PDFInfo
- Publication number
- DE60035316T2 DE60035316T2 DE60035316T DE60035316T DE60035316T2 DE 60035316 T2 DE60035316 T2 DE 60035316T2 DE 60035316 T DE60035316 T DE 60035316T DE 60035316 T DE60035316 T DE 60035316T DE 60035316 T2 DE60035316 T2 DE 60035316T2
- Authority
- DE
- Germany
- Prior art keywords
- liquid
- analyte
- zone
- detectable
- reagent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 464
- 238000000034 method Methods 0.000 title claims description 84
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 226
- 239000000376 reactant Substances 0.000 claims abstract description 157
- 238000006243 chemical reaction Methods 0.000 claims abstract description 121
- 239000000463 material Substances 0.000 claims abstract description 113
- 210000004369 blood Anatomy 0.000 claims abstract description 28
- 239000008280 blood Substances 0.000 claims abstract description 28
- 239000012491 analyte Substances 0.000 claims description 222
- 239000007795 chemical reaction product Substances 0.000 claims description 118
- 239000000047 product Substances 0.000 claims description 75
- 238000010521 absorption reaction Methods 0.000 claims description 51
- 239000000758 substrate Substances 0.000 claims description 40
- 102000004190 Enzymes Human genes 0.000 claims description 30
- 108090000790 Enzymes Proteins 0.000 claims description 30
- 239000012530 fluid Substances 0.000 claims description 25
- 230000015572 biosynthetic process Effects 0.000 claims description 23
- 238000009739 binding Methods 0.000 claims description 19
- 230000008859 change Effects 0.000 claims description 17
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 16
- 239000000020 Nitrocellulose Substances 0.000 claims description 16
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 16
- 239000008103 glucose Substances 0.000 claims description 16
- 229920001220 nitrocellulos Polymers 0.000 claims description 16
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims description 15
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims description 15
- 230000007704 transition Effects 0.000 claims description 15
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 claims description 14
- 210000003743 erythrocyte Anatomy 0.000 claims description 14
- 108010088751 Albumins Proteins 0.000 claims description 13
- 102000009027 Albumins Human genes 0.000 claims description 13
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 12
- 239000011575 calcium Substances 0.000 claims description 12
- 229910052791 calcium Inorganic materials 0.000 claims description 12
- 239000012634 fragment Substances 0.000 claims description 9
- 239000011777 magnesium Substances 0.000 claims description 9
- 229910052749 magnesium Inorganic materials 0.000 claims description 9
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 8
- 235000012000 cholesterol Nutrition 0.000 claims description 8
- 102000005962 receptors Human genes 0.000 claims description 8
- 108020003175 receptors Proteins 0.000 claims description 8
- 239000004382 Amylase Substances 0.000 claims description 7
- 102000013142 Amylases Human genes 0.000 claims description 7
- 108010065511 Amylases Proteins 0.000 claims description 7
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 claims description 7
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 claims description 7
- 235000019418 amylase Nutrition 0.000 claims description 7
- 229940109239 creatinine Drugs 0.000 claims description 7
- 229940116269 uric acid Drugs 0.000 claims description 7
- 238000004020 luminiscence type Methods 0.000 claims description 5
- 239000004800 polyvinyl chloride Substances 0.000 claims description 5
- 229920000915 polyvinyl chloride Polymers 0.000 claims description 5
- 235000018102 proteins Nutrition 0.000 claims description 5
- 102000004169 proteins and genes Human genes 0.000 claims description 5
- 108090000623 proteins and genes Proteins 0.000 claims description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 4
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 claims description 4
- 229920002799 BoPET Polymers 0.000 claims description 4
- 239000005041 Mylar™ Substances 0.000 claims description 4
- 102000005936 beta-Galactosidase Human genes 0.000 claims description 4
- 108010005774 beta-Galactosidase Proteins 0.000 claims description 4
- 108040007629 peroxidase activity proteins Proteins 0.000 claims description 4
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 claims description 3
- 108010082126 Alanine transaminase Proteins 0.000 claims description 3
- 108010003415 Aspartate Aminotransferases Proteins 0.000 claims description 3
- 102000004625 Aspartate Aminotransferases Human genes 0.000 claims description 3
- 102000004420 Creatine Kinase Human genes 0.000 claims description 3
- 108010042126 Creatine kinase Proteins 0.000 claims description 3
- 230000035699 permeability Effects 0.000 claims description 3
- 229920006267 polyester film Polymers 0.000 claims description 3
- 102000017727 Immunoglobulin Variable Region Human genes 0.000 claims description 2
- 108010067060 Immunoglobulin Variable Region Proteins 0.000 claims description 2
- 102000003855 L-lactate dehydrogenase Human genes 0.000 claims description 2
- 108700023483 L-lactate dehydrogenases Proteins 0.000 claims description 2
- 102000004882 Lipase Human genes 0.000 claims description 2
- 108090001060 Lipase Proteins 0.000 claims description 2
- 239000004367 Lipase Substances 0.000 claims description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 2
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 claims description 2
- 229910021529 ammonia Inorganic materials 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 235000019421 lipase Nutrition 0.000 claims description 2
- 239000011574 phosphorus Substances 0.000 claims description 2
- 229910052698 phosphorus Inorganic materials 0.000 claims description 2
- 238000002834 transmittance Methods 0.000 claims description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 2
- 230000002427 irreversible effect Effects 0.000 claims 2
- 102000013415 peroxidase activity proteins Human genes 0.000 claims 1
- 238000001514 detection method Methods 0.000 abstract description 10
- 210000002966 serum Anatomy 0.000 abstract description 10
- 210000002381 plasma Anatomy 0.000 abstract description 7
- 239000013060 biological fluid Substances 0.000 abstract description 4
- 230000006872 improvement Effects 0.000 abstract description 3
- 210000002700 urine Anatomy 0.000 abstract description 3
- 230000007613 environmental effect Effects 0.000 abstract description 2
- 235000013336 milk Nutrition 0.000 abstract description 2
- 239000008267 milk Substances 0.000 abstract description 2
- 210000004080 milk Anatomy 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 abstract 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 221
- 239000000243 solution Substances 0.000 description 57
- 238000012360 testing method Methods 0.000 description 55
- 238000003556 assay Methods 0.000 description 52
- 239000003085 diluting agent Substances 0.000 description 45
- 239000002250 absorbent Substances 0.000 description 30
- 230000002745 absorbent Effects 0.000 description 30
- 239000012528 membrane Substances 0.000 description 30
- 229940088598 enzyme Drugs 0.000 description 23
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 18
- 239000012894 fetal calf serum Substances 0.000 description 18
- 239000000975 dye Substances 0.000 description 13
- 238000005259 measurement Methods 0.000 description 13
- 239000000126 substance Substances 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 238000004458 analytical method Methods 0.000 description 9
- 230000007480 spreading Effects 0.000 description 8
- 238000003892 spreading Methods 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 7
- 230000002255 enzymatic effect Effects 0.000 description 7
- 230000002452 interceptive effect Effects 0.000 description 7
- 239000004695 Polyether sulfone Substances 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 229920006393 polyether sulfone Polymers 0.000 description 6
- 239000011148 porous material Substances 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 108020004206 Gamma-glutamyltransferase Proteins 0.000 description 5
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 5
- 102000006640 gamma-Glutamyltransferase Human genes 0.000 description 5
- 238000003384 imaging method Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 239000001008 quinone-imine dye Substances 0.000 description 5
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 4
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 4
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 3
- 102000003992 Peroxidases Human genes 0.000 description 3
- 238000012356 Product development Methods 0.000 description 3
- 238000000862 absorption spectrum Methods 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- -1 polyethylene Polymers 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 241000894007 species Species 0.000 description 3
- BCHIXGBGRHLSBE-UHFFFAOYSA-N (4-methyl-2-oxochromen-7-yl) dihydrogen phosphate Chemical compound C1=C(OP(O)(O)=O)C=CC2=C1OC(=O)C=C2C BCHIXGBGRHLSBE-UHFFFAOYSA-N 0.000 description 2
- KUWPCJHYPSUOFW-YBXAARCKSA-N 2-nitrophenyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1[N+]([O-])=O KUWPCJHYPSUOFW-YBXAARCKSA-N 0.000 description 2
- FEPBITJSIHRMRT-UHFFFAOYSA-N 4-hydroxybenzenesulfonic acid Chemical compound OC1=CC=C(S(O)(=O)=O)C=C1 FEPBITJSIHRMRT-UHFFFAOYSA-N 0.000 description 2
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 2
- 239000004366 Glucose oxidase Substances 0.000 description 2
- 108010015776 Glucose oxidase Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 239000010836 blood and blood product Substances 0.000 description 2
- 229940125691 blood product Drugs 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000003365 glass fiber Substances 0.000 description 2
- 229940116332 glucose oxidase Drugs 0.000 description 2
- 235000019420 glucose oxidase Nutrition 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000002310 reflectometry Methods 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- IQUPABOKLQSFBK-UHFFFAOYSA-N 2-nitrophenol Chemical compound OC1=CC=CC=C1[N+]([O-])=O IQUPABOKLQSFBK-UHFFFAOYSA-N 0.000 description 1
- HSTOKWSFWGCZMH-UHFFFAOYSA-N 3,3'-diaminobenzidine Chemical compound C1=C(N)C(N)=CC=C1C1=CC=C(N)C(N)=C1 HSTOKWSFWGCZMH-UHFFFAOYSA-N 0.000 description 1
- MKNQNPYGAQGARI-UHFFFAOYSA-N 4-(bromomethyl)phenol Chemical compound OC1=CC=C(CBr)C=C1 MKNQNPYGAQGARI-UHFFFAOYSA-N 0.000 description 1
- LVSPDZAGCBEQAV-UHFFFAOYSA-N 4-chloronaphthalen-1-ol Chemical compound C1=CC=C2C(O)=CC=C(Cl)C2=C1 LVSPDZAGCBEQAV-UHFFFAOYSA-N 0.000 description 1
- KZZWQCKYLNIOBT-UHFFFAOYSA-N 5-amino-2-nitrobenzoic acid Chemical compound NC1=CC=C([N+]([O-])=O)C(C(O)=O)=C1 KZZWQCKYLNIOBT-UHFFFAOYSA-N 0.000 description 1
- QRXMUCSWCMTJGU-UHFFFAOYSA-N 5-bromo-4-chloro-3-indolyl phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP(O)(=O)O)=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-N 0.000 description 1
- OXEUETBFKVCRNP-UHFFFAOYSA-N 9-ethyl-3-carbazolamine Chemical compound NC1=CC=C2N(CC)C3=CC=CC=C3C2=C1 OXEUETBFKVCRNP-UHFFFAOYSA-N 0.000 description 1
- 238000008940 Alkaline Phosphatase assay kit Methods 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 238000008620 Cholesterol Assay Methods 0.000 description 1
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 239000012445 acidic reagent Substances 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 238000002820 assay format Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- RIIWUGSYXOBDMC-UHFFFAOYSA-N benzene-1,2-diamine;hydron;dichloride Chemical compound Cl.Cl.NC1=CC=CC=C1N RIIWUGSYXOBDMC-UHFFFAOYSA-N 0.000 description 1
- OHJMTUPIZMNBFR-UHFFFAOYSA-N biuret Chemical compound NC(=O)NC(N)=O OHJMTUPIZMNBFR-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 239000007805 chemical reaction reactant Substances 0.000 description 1
- 238000006757 chemical reactions by type Methods 0.000 description 1
- 238000013098 chemical test method Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000002848 electrochemical method Methods 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 238000007824 enzymatic assay Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- LIIALPBMIOVAHH-UHFFFAOYSA-N herniarin Chemical compound C1=CC(=O)OC2=CC(OC)=CC=C21 LIIALPBMIOVAHH-UHFFFAOYSA-N 0.000 description 1
- JHGVLAHJJNKSAW-UHFFFAOYSA-N herniarin Natural products C1CC(=O)OC2=CC(OC)=CC=C21 JHGVLAHJJNKSAW-UHFFFAOYSA-N 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 239000000553 indicators and reagents Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000012933 kinetic analysis Methods 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- ZLQJVGSVJRBUNL-UHFFFAOYSA-N methylumbelliferone Natural products C1=C(O)C=C2OC(=O)C(C)=CC2=C1 ZLQJVGSVJRBUNL-UHFFFAOYSA-N 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 229950006238 nadide Drugs 0.000 description 1
- JPXMTWWFLBLUCD-UHFFFAOYSA-N nitro blue tetrazolium(2+) Chemical compound COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 JPXMTWWFLBLUCD-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000012634 optical imaging Methods 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 210000004180 plasmocyte Anatomy 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 238000002731 protein assay Methods 0.000 description 1
- 238000000159 protein binding assay Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 150000004060 quinone imines Chemical class 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/91—Xanthomonas
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US277715 | 1999-03-26 | ||
| US09/277,715 US6602719B1 (en) | 1999-03-26 | 1999-03-26 | Method and device for detecting analytes in fluids |
| US09/439,024 US6511814B1 (en) | 1999-03-26 | 1999-11-12 | Method and device for detecting analytes in fluids |
| US439024 | 1999-11-12 | ||
| US09/525,151 US6551842B1 (en) | 1999-03-26 | 2000-03-14 | Method and device for detecting analytes in fluids |
| US525151 | 2000-03-14 | ||
| PCT/US2000/007965 WO2000058730A1 (en) | 1999-03-26 | 2000-03-24 | Method and device for detecting analytes in fluids |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60035316D1 DE60035316D1 (de) | 2007-08-09 |
| DE60035316T2 true DE60035316T2 (de) | 2008-03-06 |
Family
ID=27402933
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60035316T Expired - Fee Related DE60035316T2 (de) | 1999-03-26 | 2000-03-24 | Vorrichtung und verfahren zur detektion von analyten in flüssigkeiten |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6551842B1 (enExample) |
| EP (1) | EP1082614B1 (enExample) |
| JP (1) | JP2002540427A (enExample) |
| AT (1) | ATE365918T1 (enExample) |
| AU (1) | AU773121B2 (enExample) |
| BR (1) | BR0006058A (enExample) |
| CA (1) | CA2332240A1 (enExample) |
| DE (1) | DE60035316T2 (enExample) |
| WO (1) | WO2000058730A1 (enExample) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000015544A1 (de) * | 1998-09-12 | 2000-03-23 | Universität Gesamthochschule Kassel | Apertur in einem halbleitermaterial sowie herstellung der apertur und verwendung |
| US6136610A (en) | 1998-11-23 | 2000-10-24 | Praxsys Biosystems, Inc. | Method and apparatus for performing a lateral flow assay |
| US6528323B1 (en) | 1999-06-14 | 2003-03-04 | Praxsys Biosystems, Inc. | Bidirectional lateral flow test strip and method |
| AU2002330899B2 (en) * | 2001-07-18 | 2008-03-06 | Relia Diagnostic Systems, Inc. | Test strip for a lateral flow assay |
| US6723500B2 (en) * | 2001-12-05 | 2004-04-20 | Lifescan, Inc. | Test strips having reaction zones and channels defined by a thermally transferred hydrophobic barrier |
| US7425302B2 (en) | 2003-02-24 | 2008-09-16 | Binax, Inc. | Dry chemistry, lateral flow-reconstituted chromatographic enzyme-driven assays |
| US20060076295A1 (en) | 2004-03-15 | 2006-04-13 | The Trustees Of Columbia University In The City Of New York | Systems and methods of blood-based therapies having a microfluidic membraneless exchange device |
| WO2004082796A2 (en) | 2003-03-14 | 2004-09-30 | The Trustees Of Columbia University In The City Ofnew York | Systems and methods of blood-based therapies having a microfluidic membraneless exchange device |
| GB0403369D0 (en) * | 2004-02-16 | 2004-03-17 | Pa Consulting Services | Devices and methods for testing analytes |
| DE602005023183D1 (de) * | 2004-07-29 | 2010-10-07 | Relia Diagnostic Systems Llc | Querstromsystem und assay |
| US7442557B1 (en) | 2004-10-22 | 2008-10-28 | Idexx Laboratories, Inc. | Bi-directional flow assay device with reagent bridge |
| US7545272B2 (en) | 2005-02-08 | 2009-06-09 | Therasense, Inc. | RF tag on test strips, test strip vials and boxes |
| WO2006098804A2 (en) | 2005-03-11 | 2006-09-21 | Chembio Diagnostic Systems, Inc. | Dual path immunoassay device |
| US7189522B2 (en) | 2005-03-11 | 2007-03-13 | Chembio Diagnostic Systems, Inc. | Dual path immunoassay device |
| US7939342B2 (en) | 2005-03-30 | 2011-05-10 | Kimberly-Clark Worldwide, Inc. | Diagnostic test kits employing an internal calibration system |
| CA2652173A1 (en) * | 2006-05-22 | 2007-11-29 | Edward F. Leonard | Systems and methods of microfluidic membraneless exchange using filtration of extraction fluid outlet streams |
| CN100580426C (zh) * | 2006-11-06 | 2010-01-13 | 五鼎生物技术股份有限公司 | 定量分析酶抑制剂的检测装置及方法 |
| GB2450351B (en) | 2007-06-20 | 2012-01-18 | Cozart Bioscience Ltd | Monitoring an Immunoassay |
| EP2198299A4 (en) * | 2007-10-18 | 2010-09-29 | Momtec Life Ltd | DIAGNOSTIC DEVICE FOR IDENTIFICATION OF MEMBRANE RIPS DURING PREGNANCY |
| EP2090365A1 (en) | 2008-01-23 | 2009-08-19 | Koninklijke Philips Electronics N.V. | Combined cell and protein analysis on a substrate |
| AU2009212396A1 (en) * | 2008-02-04 | 2009-08-13 | The Trustees Of Columbia University In The City Of New York | Fluid separation devices, systems and methods |
| US20100022916A1 (en) | 2008-07-24 | 2010-01-28 | Javanbakhsh Esfandiari | Method and Apparatus for Collecting and Preparing Biological Samples for Testing |
| JP5893552B2 (ja) | 2009-04-07 | 2016-03-23 | ネクサス・ディーエックス・インコーポレイテッドＮｅｘｕｓ Ｄｘ， Ｉｎｃ． | ポイントオブケア・テストの結果を読み取るためのハンドヘルド・スキャナ・システム及び方法 |
| US20100317033A1 (en) * | 2009-06-10 | 2010-12-16 | Matthew Philip Abdel | Methods and materials for detecting food containing allergens |
| US20120301370A1 (en) * | 2010-02-15 | 2012-11-29 | Carnegie Mellon University | Apparatus and Process for Producing Patterned, Micron and Nanometer Size Reaction and Mixing Zones for Fluids Deposited on Smooth, Rough and Porous Surfaces and Applications of that Process |
| WO2011104238A1 (en) * | 2010-02-23 | 2011-09-01 | B.R.A.H.M.S Gmbh | A method for determining a marker in small volume of a sample of a bodily fluid |
| US8603835B2 (en) | 2011-02-10 | 2013-12-10 | Chembio Diagnostic Systems, Inc. | Reduced step dual path immunoassay device and method |
| DK2760998T3 (en) * | 2011-11-22 | 2017-04-24 | Siemens Healthcare Diagnostics Inc | Devices with dried reagents for reconstitution as calibration and / or quality control solutions, and methods of preparation and use thereof |
| CN111077309B (zh) | 2014-04-02 | 2023-11-17 | 生化诊断系统公司 | 利用俘获缀合物的免疫测定 |
| US20160116466A1 (en) | 2014-10-27 | 2016-04-28 | Chembio Diagnostic Systems, Inc. | Rapid Screening Assay for Qualitative Detection of Multiple Febrile Illnesses |
| US10677780B2 (en) * | 2014-12-17 | 2020-06-09 | Siemens Healthcare Diagnostics Inc. | Compositions, kits, and devices for generating and accurately measuring different oxygen levels in calibration and/or quality control reagents and methods of production and use thereof |
| US9759651B2 (en) | 2014-12-23 | 2017-09-12 | Magellan Diagnostics, Inc. | Combination optical hemoglobin and electrochemical lead assay |
| JP2019507339A (ja) | 2016-01-27 | 2019-03-14 | アンダーカバー カラーズ，インク． | 液体中の化合物を検出するための方法および装置 |
| CN113748321B (zh) * | 2018-11-29 | 2024-09-06 | 前沿诊疗股份有限公司 | 单次使用的临床分光光度计 |
| TWI791933B (zh) * | 2019-01-07 | 2023-02-11 | 美商伊路米納有限公司 | 用於檢測和分析流體的系統和方法 |
| CN111678755B (zh) * | 2020-05-21 | 2023-09-19 | 桂林优利特医疗电子有限公司 | 一种尿液有形成分分析仪用管型质控物及其制备方法 |
| CN114280312B (zh) * | 2020-09-27 | 2023-09-15 | 河北特温特生物科技发展有限公司 | 一种用于免疫荧光层析检测的全血分离膜及其制备方法和应用 |
| WO2023095132A1 (en) * | 2021-11-23 | 2023-06-01 | Labrador Sciences Ltd. | Self-calibrating diagnostic device and systems and methods for use thereof |
Family Cites Families (90)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3607093A (en) | 1968-02-15 | 1971-09-21 | Schering Corp | Devices for testing biological liquids |
| US3615222A (en) | 1968-09-04 | 1971-10-26 | New England Nuclear Corp | Method and apparatus for measuring the amount of a component in a biological fluid |
| US3811840A (en) | 1969-04-01 | 1974-05-21 | Miles Lab | Test device for detecting low concentrations of substances in fluids |
| US3791933A (en) | 1971-02-25 | 1974-02-12 | Geomet | Rapid methods for assay of enzyme substrates and metabolites |
| DE2118455B1 (de) | 1971-04-16 | 1972-09-21 | Boehringer Mannheim Gmbh | Teststreifen |
| BE786291A (fr) | 1971-07-20 | 1973-01-15 | Technicon Instr | Compositions de diagnostic pour determination de la glutamate-oxalate-transaminase (got) et de la glutamate-pyruvate-transaminase (gpt) |
| US3801466A (en) | 1971-12-02 | 1974-04-02 | American Monitor Corp | Uric acid assay and reagents therefor |
| US4059405A (en) | 1972-04-11 | 1977-11-22 | Damon Corporation | Method and apparatus for analysis of constituent carried in fibrous medium |
| US3902052A (en) | 1973-06-11 | 1975-08-26 | Technicon Instr | Method and apparatus for the peak monitoring the results of analysis apparatus |
| US3992158A (en) | 1973-08-16 | 1976-11-16 | Eastman Kodak Company | Integral analytical element |
| DE2436598C2 (de) | 1974-07-30 | 1983-04-07 | Boehringer Mannheim Gmbh, 6800 Mannheim | Stabiler Teststreifen zum Nachweis von Inhaltsstoffen in Flüssigkeiten |
| US3964871A (en) | 1974-12-18 | 1976-06-22 | Becton, Dickinson And Company | Method and device for detecting glucose |
| JPS51114985A (en) | 1975-04-01 | 1976-10-09 | Kyoto Daiichi Kagaku:Kk | Mothod to analyse urine, etc. |
| US4042335A (en) | 1975-07-23 | 1977-08-16 | Eastman Kodak Company | Integral element for analysis of liquids |
| FR2341865A1 (fr) | 1976-02-19 | 1977-09-16 | Api Labor | Support pour le dosage d'activites enzymatiques et procede de dosage a l'aide de ce support |
| US4160008A (en) | 1978-01-26 | 1979-07-03 | Miles Laboratories, Inc. | Multilayered test device for determining the presence of a liquid sample component, and method of use |
| US4233029A (en) | 1978-10-25 | 1980-11-11 | Eastman Kodak Company | Liquid transport device and method |
| US4288228A (en) | 1979-01-31 | 1981-09-08 | Technicon Instruments Corporation | Whole blood analyses and diffusion apparatus therefor |
| US4303408A (en) | 1980-02-05 | 1981-12-01 | Eastman Kodak Company | Removal of interferents in analytical assays in a two phase interferent-removal zone |
| US4426451A (en) | 1981-01-28 | 1984-01-17 | Eastman Kodak Company | Multi-zoned reaction vessel having pressure-actuatable control means between zones |
| US4588696A (en) | 1983-02-17 | 1986-05-13 | Eskelson Cleamond D | Pellet process for the detection of formaldehyde and/or glutaraldehyde |
| US4734360A (en) | 1983-07-12 | 1988-03-29 | Lifescan, Inc. | Colorimetric ethanol analysis method and test device |
| US4637978A (en) | 1983-10-28 | 1987-01-20 | Eastman Kodak Company | Assay for analysis of whole blood |
| US4594327A (en) | 1983-11-02 | 1986-06-10 | Syntex (U.S.A.) Inc. | Assay method for whole blood samples |
| EP0165288B1 (en) | 1983-12-02 | 1990-03-14 | Vertrik Bioteknik Ab | A device for chemical analyses and use thereof |
| US4654127A (en) | 1984-04-11 | 1987-03-31 | Sentech Medical Corporation | Self-calibrating single-use sensing device for clinical chemistry and method of use |
| JPH0673472B2 (ja) | 1985-02-05 | 1994-09-21 | コニカ株式会社 | 分析素子 |
| US4627918A (en) | 1985-11-04 | 1986-12-09 | Sepragen Corporation | Chromatography column using horizontal flow |
| US4962021A (en) | 1986-06-20 | 1990-10-09 | Personal Diagnostics, Inc. | Analyte determination using gel including a reagent system reacts with analyte to change transmissive property of gel detectable by light beam transmitted through gel by total internal reflectance |
| US4812400A (en) | 1986-07-14 | 1989-03-14 | Steinman Gary D | Process for measuring sodium levels in biological fluids |
| US4935346A (en) | 1986-08-13 | 1990-06-19 | Lifescan, Inc. | Minimum procedure system for the determination of analytes |
| US4790979A (en) | 1986-08-29 | 1988-12-13 | Technimed Corporation | Test strip and fixture |
| DE3638654A1 (de) | 1986-11-12 | 1988-05-26 | Boehringer Mannheim Gmbh | Testtraeger zur analytischen bestimmung eines bestandteils einer koerperfluessigkeit |
| CA1338736C (fr) | 1986-12-05 | 1996-11-26 | Roger Baurain | Microcristaux comportant une substance active presentant une affinite pour les phospholipides, et au moins un phospholipide, procede de preparation |
| US4774192A (en) | 1987-01-28 | 1988-09-27 | Technimed Corporation | A dry reagent delivery system with membrane having porosity gradient |
| US4800162A (en) | 1987-04-01 | 1989-01-24 | Sepracor, Inc. | Method for resolution of steroisomers in multiphase and extractive membrane reactors |
| US4857453A (en) | 1987-04-07 | 1989-08-15 | Syntex (U.S.A.) Inc. | Immunoassay device |
| US4943522A (en) | 1987-06-01 | 1990-07-24 | Quidel | Lateral flow, non-bibulous membrane assay protocols |
| US5104793A (en) | 1988-02-16 | 1992-04-14 | Boehringer Mannheim Corporation | Method for determining an analyte in a liquid sample using a zoned test device and an inhibitor for a label used in said method |
| US5096809A (en) | 1988-07-25 | 1992-03-17 | Pacific Biotech, Inc. | Whole blood assays using porous membrane support devices |
| US5082626A (en) | 1988-08-08 | 1992-01-21 | Boehringer Mannheim Gmbh | Wedge shaped test strip system useful in analyzing test samples, such as whole blood |
| US5252293A (en) | 1989-01-17 | 1993-10-12 | Vladimir Drbal | Analytical slide with porous filter membrane |
| US5114350A (en) | 1989-03-08 | 1992-05-19 | Cholestech Corporation | Controlled-volume assay apparatus |
| US5135716A (en) | 1989-07-12 | 1992-08-04 | Kingston Diagnostics, L.P. | Direct measurement of HDL cholesterol via dry chemistry strips |
| DK374889D0 (da) | 1989-07-28 | 1989-07-28 | Koege Kemisk Vaerk | Fremgangsmaade til procesovervaagning |
| US5104812A (en) | 1989-11-27 | 1992-04-14 | Syntex (U.S.A.) Inc. | Device and method for interrupting capillary flow |
| JP2618727B2 (ja) | 1990-01-19 | 1997-06-11 | 富士写真フイルム株式会社 | 全血中の被検成分の定量方法 |
| US5141850A (en) | 1990-02-07 | 1992-08-25 | Hygeia Sciences, Inc. | Porous strip form assay device method |
| US5091188A (en) | 1990-04-26 | 1992-02-25 | Haynes Duncan H | Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs |
| US5212060A (en) | 1990-04-27 | 1993-05-18 | Genesis Labs, Inc. | Dry test strip comprising a dextran barrier for excluding erythrocytes |
| SE465086B (sv) | 1990-05-16 | 1991-07-22 | Mats Malmquist | Reagenskapillaerer, reaktionskaerl, beredningssaett och anvaendning daerav |
| US5187100A (en) | 1990-05-29 | 1993-02-16 | Lifescan, Inc. | Dispersion to limit penetration of aqueous solutions into a membrane |
| US5186844A (en) | 1991-04-01 | 1993-02-16 | Abaxis, Inc. | Apparatus and method for continuous centrifugal blood cell separation |
| US5061381A (en) | 1990-06-04 | 1991-10-29 | Abaxis, Inc. | Apparatus and method for separating cells from biological fluids |
| US5242606A (en) | 1990-06-04 | 1993-09-07 | Abaxis, Incorporated | Sample metering port for analytical rotor having overflow chamber |
| US5122284A (en) | 1990-06-04 | 1992-06-16 | Abaxis, Inc. | Apparatus and method for optically analyzing biological fluids |
| US5147606A (en) | 1990-08-06 | 1992-09-15 | Miles Inc. | Self-metering fluid analysis device |
| US5726064A (en) | 1990-11-22 | 1998-03-10 | Applied Research Systems Ars Holding Nv | Method of assay having calibration within the assay |
| US6027944A (en) | 1990-11-22 | 2000-02-22 | Applied Research Systems Ars Holding Nv | Capillary-fill biosensor device comprising a calibration zone |
| WO1992012257A1 (en) | 1990-12-28 | 1992-07-23 | Baxter Diagnostics Inc. | Method and composition for determining antimicrobial susceptibility of the majority of clinically significant gram positive organisms |
| US5877028A (en) | 1991-05-29 | 1999-03-02 | Smithkline Diagnostics, Inc. | Immunochromatographic assay device |
| DE69110032T2 (de) | 1991-06-08 | 1995-12-21 | Hewlett Packard Gmbh | Verfahren und Gerät zur Feststellung und/oder Konzentrationsbestimmung von Biomolekülen. |
| US6007999A (en) | 1991-07-31 | 1999-12-28 | Idexx Laboratories, Inc. | Reversible flow chromatographic binding assay |
| US5726010A (en) | 1991-07-31 | 1998-03-10 | Idexx Laboratories, Inc. | Reversible flow chromatographic binding assay |
| US5413732A (en) | 1991-08-19 | 1995-05-09 | Abaxis, Inc. | Reagent compositions for analytical testing |
| WO1993008684A1 (en) | 1991-10-28 | 1993-05-13 | Steinman Gary D | Process and device for measuring magnesium in biological fluids and method of preparing the device |
| US5304348A (en) | 1992-02-11 | 1994-04-19 | Abaxis, Inc. | Reagent container for analytical rotor |
| WO1993019827A1 (en) | 1992-04-02 | 1993-10-14 | Abaxis, Inc. | Analytical rotor with dye mixing chamber |
| AU689768B2 (en) | 1993-02-17 | 1998-04-09 | Cardiovascular Diagnostics, Inc. | Dry chemistry cascade immunoassay and affinity assay |
| US5478750A (en) | 1993-03-31 | 1995-12-26 | Abaxis, Inc. | Methods for photometric analysis |
| US5409665A (en) | 1993-09-01 | 1995-04-25 | Abaxis, Inc. | Simultaneous cuvette filling with means to isolate cuvettes |
| US5591643A (en) | 1993-09-01 | 1997-01-07 | Abaxis, Inc. | Simplified inlet channels |
| US5408535A (en) | 1993-09-07 | 1995-04-18 | Miles Inc. | Video test strip reader and method for evaluating test strips |
| US5403415A (en) | 1993-11-17 | 1995-04-04 | Abaxis, Inc. | Method and device for ultrasonic welding |
| GB9325718D0 (en) | 1993-12-16 | 1994-02-16 | Ars Holding 89 Nv | Sensor device for sandwich assay |
| US5779867A (en) | 1994-10-07 | 1998-07-14 | Biomedix, Inc. | Dry chemistry glucose sensor |
| ATE334392T1 (de) | 1995-05-09 | 2006-08-15 | Beckman Coulter Inc | Vorrichtungen und verfahren zur abtrennung zellulärer blutkomponenten von flüssigen blutanteilen |
| WO1996036878A1 (en) | 1995-05-19 | 1996-11-21 | Universal Healthwatch, Inc. | Rapid self-contained assay format |
| US5716852A (en) | 1996-03-29 | 1998-02-10 | University Of Washington | Microfabricated diffusion-based chemical sensor |
| AUPN527995A0 (en) * | 1995-09-07 | 1995-09-28 | Agen Biomedical Limited | Method and apparatus for semiquantification of an analyte |
| US5981298A (en) | 1995-12-13 | 1999-11-09 | Surmodics, Inc. | Immunoassay device and method |
| US5753497A (en) | 1995-12-22 | 1998-05-19 | Universal Health Watch Inc | Diagnostic assay providing blood separation |
| US5948684A (en) | 1997-03-31 | 1999-09-07 | University Of Washington | Simultaneous analyte determination and reference balancing in reference T-sensor devices |
| US5776719A (en) | 1997-07-07 | 1998-07-07 | Mercury Diagnostics, Inc. | Diagnostic compositions and devices utilizing same |
| US5802842A (en) | 1996-07-29 | 1998-09-08 | Trw Inc. | Dimensionally stable throat insert for rocket thrusters |
| US6001658A (en) | 1996-09-13 | 1999-12-14 | Diagnostic Chemicals Limited | Test strip apparatus and method for determining presence of analyte in a fluid sample |
| US5998221A (en) | 1996-09-25 | 1999-12-07 | Becton, Dickinson And Company | Non-instrumented assay with quantitative and qualitative results |
| US5989924A (en) | 1997-09-30 | 1999-11-23 | Becton, Dickinson And Company | Device for determining an analyte in a sample |
| US5962336A (en) | 1997-10-20 | 1999-10-05 | Sun; Ming | Multi-test panel |
| US6136610A (en) | 1998-11-23 | 2000-10-24 | Praxsys Biosystems, Inc. | Method and apparatus for performing a lateral flow assay |
-
2000
- 2000-03-14 US US09/525,151 patent/US6551842B1/en not_active Expired - Lifetime
- 2000-03-24 BR BR0006058-5A patent/BR0006058A/pt not_active Application Discontinuation
- 2000-03-24 WO PCT/US2000/007965 patent/WO2000058730A1/en not_active Ceased
- 2000-03-24 AU AU40299/00A patent/AU773121B2/en not_active Ceased
- 2000-03-24 CA CA002332240A patent/CA2332240A1/en not_active Abandoned
- 2000-03-24 AT AT00919643T patent/ATE365918T1/de not_active IP Right Cessation
- 2000-03-24 EP EP00919643A patent/EP1082614B1/en not_active Expired - Lifetime
- 2000-03-24 JP JP2000608177A patent/JP2002540427A/ja active Pending
- 2000-03-24 DE DE60035316T patent/DE60035316T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000058730A9 (en) | 2002-07-11 |
| ATE365918T1 (de) | 2007-07-15 |
| CA2332240A1 (en) | 2000-10-05 |
| BR0006058A (pt) | 2001-03-20 |
| WO2000058730A8 (en) | 2001-07-19 |
| DE60035316D1 (de) | 2007-08-09 |
| AU773121B2 (en) | 2004-05-20 |
| WO2000058730A1 (en) | 2000-10-05 |
| EP1082614B1 (en) | 2007-06-27 |
| US6551842B1 (en) | 2003-04-22 |
| AU4029900A (en) | 2000-10-16 |
| EP1082614A1 (en) | 2001-03-14 |
| JP2002540427A (ja) | 2002-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60035316T2 (de) | Vorrichtung und verfahren zur detektion von analyten in flüssigkeiten | |
| US6511814B1 (en) | Method and device for detecting analytes in fluids | |
| DE69826583T2 (de) | Vorrichtung und Verfahren zum Erreichen von klinischen wichtigen Analytverhältnissen | |
| DE68927777T2 (de) | Testvorrichtung mit definiertem Volumen | |
| DE69714637T2 (de) | Reagenzteststreifen zum Nachweis von Glukose im Blut | |
| DE60129042T2 (de) | Teststreifen für den gleichzeitigen nachweis mehrerer analyten | |
| DE69727579T2 (de) | Trockenreagenz-Teststreifen mit einem Benzindinfarbstoff-Vorläufer und einer Antipyrinverbindung | |
| DE69320437T2 (de) | Analysenkassette und system zum aufspüren von analyten | |
| DE68909568T2 (de) | Analytisches Testgerät. | |
| US4144306A (en) | Element for analysis of liquids | |
| US4069016A (en) | Assay for bilirubin | |
| DE69636775T2 (de) | Kombinationstest für den aktuellen glukosespiegel und die mittel- oder langfristige blutzuckerkontrolle | |
| JP2002540427A5 (enExample) | ||
| DE60121404T2 (de) | Biosensor | |
| US6602719B1 (en) | Method and device for detecting analytes in fluids | |
| DE69526347T2 (de) | Mehrschichtuge testvorrichtungen und verfahren zur fructosaminbestimmung | |
| DE2532918C3 (de) | Integrales analytisches Element für die Analyse von Flüssigkeiten | |
| DE2717817A1 (de) | Analytisches element | |
| DE68914411T2 (de) | Vorrichtung und Verfahren zum Testen einer flüssigen Probe. | |
| DE69121447T2 (de) | Immuntestelement und Verfahren für Immuntest | |
| DE69228963T2 (de) | Verfahren zur Bestimmung von Analyte unter Verwendung eines trockenen analytischen Elements | |
| DE3783851T2 (de) | Integrales, mehrschichtiges element fuer analyse. | |
| EP1566637A1 (de) | Testelement mit Einschicht-Reaktionsfilm | |
| DE69228633T2 (de) | Verfahren zur Analyten-Bestimmung unter Verwendung eines trockenen analytischen Elements | |
| DE68916564T2 (de) | Trockenes analytisches Element und Verfahren für dessen Produktion. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |